DOMS Industries’ Subsidiary Faces GST Input Tax Credit Order With Limited Impact

DOMS Industries Limited ( (IN:DOMS) ) has provided an update.

DOMS Industries has reported that its subsidiary, Uniclan Healthcare Private Limited, received an order from the Office of the Superintendent of Central Taxes in Thane under provisions of the CGST and MGST Acts for wrongful availment and utilisation of input tax credit without actual receipt of goods or services. The order, relating to FY 2021-22 and received on March 20, 2026, seeks recovery of alleged inadmissible ITC of ₹5,22,692, along with a penalty of ₹10,45,384 and interest, though the company maintains that the matter will be contested through appropriate legal remedies and states that the order does not have a material impact on its financials or operations.

The company has indicated that its subsidiary is evaluating legal options and intends to respond within the prescribed time limits, signalling that it is actively managing the tax dispute while reassuring stakeholders about limited operational and financial implications. This disclosure under SEBI’s Regulation 30 highlights DOMS Industries’ compliance with listing obligations and suggests that, despite the tax demand on the subsidiary, the group’s overall business activities and strategic positioning remain unaffected in any significant way.

More about DOMS Industries Limited

DOMS Industries Limited operates in the manufacturing sector with a presence in consumer products, and the disclosure concerns its subsidiary, Uniclan Healthcare Private Limited, which falls under healthcare-related operations. The group is listed on BSE and NSE and is subject to Indian securities and tax regulations, including SEBI LODR norms and the Central Goods and Services Tax framework.

Average Trading Volume: 15,848

Technical Sentiment Signal: Sell

Current Market Cap: 138.2B INR

See more data about DOMS stock on TipRanks’ Stock Analysis page.